Editorial Board ::: Current Pharmaceutical Biotechnology

ISSN: 1873-4316 (Online)
ISSN: 1389-2010 (Print)


Volume 18, 15 Issues, 2017


Download PDF Flyer




Current Pharmaceutical Biotechnology

This journal supports open access

Aims & ScopeAbstracted/Indexed in

Ranking and Category:
  • 152nd of 255 in Pharmacology & Pharmacy
  • 213th of 290 in Biochemistry & Molecular Biology

Submit Abstracts Online Submit Manuscripts Online

Editor-in-Chief:
Zeno Foldes-Papp
Urban Clinical Center Soltau
University teaching hospital of Hamburg
Hamburg
Germany


View Full Editorial Board

Subscribe Purchase Articles Order Reprints

Current: 1.802
5 - Year: 2.327

Editorial Board

Editor-in-Chief:

Zeno Foldes-Papp
Urban Clinical Center Soltau
University teaching hospital of Hamburg
Hamburg
Germany



Co-Editors:

Lei Guo
Division of Biochemical Toxicology
National Center for Toxicological Research (NCTR)Food and Drug Administration (FDA)
Jefferson, AR 3900, NCTR Road, HFT-110
USA

Cheorl-Ho Kim
Molecular and Cellular Glycobiology Unit
Department of Biological Science, SungKyunKwan University
Suwon City, 440-746
South Korea

Vladimir P. Torchilin (Biography
Vladimir P. Torchilin

Vladimir P. Torchilin, Ph.D., D.Sc. is a University Distinguished Professor of Pharmaceutical Sciences and Director, Center for Pharmaceutical Biotechnology and Nanomedicine, Northeastern University, Boston. His interests include drug delivery and targeting, nanomedicine, multifunctional and stimuli-sensitive pharmaceutical nanocarriers, biomedical polymers, experimental cancer therapy. He has published more than 400 original papers, more than 150 reviews and book chapters, wrote and edited 12 books, and holds more than 40 patents. Google Scholar shows more than 44,000 citations of his papers with H-index of 96. He is Editor-in-Chief of Current Drug Discovery Technologies, Drug Delivery, and OpenNano, Co-Editor of Current Pharmaceutical Biotechnology and on the Editorial Boards of many other journals. He received more than $30 M from the governmental and industrial sources in research funding. He has multiple honors and awards and in 2011, Times Higher Education ranked him number 2 among top world scientists in pharmacology for the period of 2000-2010.

)

Department of Pharmaceutical Science Center for Pharmaceutical Biotechnology and Nanomedicine, Northeastern University
Boston, MA 02115
USA


Associate Editors:

Seng H. Cheng
Gene Transfer Research, Genzyme Corporation
Framingham, MA
USA

Cheryl I. Murphy
Aquila Biopharmaceuticals
Framingham, MA
USA

Peter H. Lu
Bowling Green State University
Bowling Green, OH
USA

Alain Rolland
AR Pharma Consulting
San Diego, CA
USA

Seth P. Monkarsh
Department of Biopharmaceuticals
Hoffmann-La Roche Inc
Nutley, NJ
USA


Section Editors:

(Cardiovascular Section)
Gjumrakch Aliev
"GALLY" International Biomedical Research Consulting LLC
San Antonio, TX
USA

(Cancer Section)
Sanjeeb K. Sahoo (Biography
Sanjeeb K. Sahoo

Dr Sahoo obtained a doctorate (Ph.D.) in chemistry from the University of Delhi, Delhi, India. Presently, Dr Sahoo is a scientist at the Institute of Life Sciences, Bhubaneswar, India. He has nearly 20 years of experience in the research related to nanotechnology based drug delivery to cancer. Dr Sahoo has authored more than 80 manuscripts, 5 patents and edited one book “Nanotechnology in Health Care”

)

Laboratory of Nanomedicine, Institute of Life Sciences, Nalco Square, Chandrasekharpur
Bhubaneswar 751023, Orissa
India

(Immunology Section)
Seyed M. Moghimi
Centre for Pharmaceutical Nanotechnology and Nanotoxicology, Faculty of Health and Medical Sciences
University of Copenhagen, DK-2100 Copenhagen
Denmark


Editorial Board Members:

Dave Allen
Lilly Research Laboratories
Indianapolis, IN
USA

Ajay K. Banga
Department of Pharmaceutical Sciences
College of Pharmacy, Mercer University
Atlanta, GA
USA

Weibo Cai
University of Wisconsin
Madison, WI
USA

Michael K. Danquah
Department of Chemical Engineering
Sarawak
Malaysia

Edward Eisenstein
Fischell Department of Bioengineering
University of Maryland
Rockville, MD
USA

Antonio Gonzalez-Bulnes (Biography
Antonio Gonzalez-Bulnes

Antonio Gonzalez-Bulnes is currently Senior Researcher and Head of the Comparative Physiology Lab at INIA. His research activities has been funded by several national and international funding bodies and its impact is determined by 187 SCI papers, 12 PhD Thesis and several books and book chapters. He has been actively involved in international collaborations and is currently member of the Managing Committee and leader of Working Group at the EU COST Action BM1308 “Sharing Advances on Large Animal Models”. He is also actively working in Research Ethics and is member of the Scientific Ethic Committee of the OPIs of the Spanish Government.

)

Comparative Physiology Lab
Madrid
Spain

Hao Hong
Department of Radiology, University of Michigan
Ann Arbor, MI
USA

Masataka Kinjo
Hokkaido University
Sapporo
Japan

Jonathan Lovell
University at Buffalo
Buffalo, NY
USA

Bruce Meiklejohn
Eli Lilly and Company
Indianapolis, IN
USA

Christoph Mulert
Department of Psychiatry
University Medical Center Hamburg
Germany

Ilkay Erdogan Orhan
Department of Pharmacognosy
Gazi University
Ankara
Turkey

Erno Pungor
Berlex Biosciences
Richmond, CA
USA

Alessandro Sette
La Jolla Inst. for Allergy & Immunology
San Diego, CA
USA

Frank Tagliaferri
Altea Therapeutics
Tucker, GA
USA

Stelios Tzannis
Nektar Therapeutics
San Carlos, CA
USA

Jia-yan Wu
Dartmouth Medical School
Hanover, NH
USA

Tom Anchordoquy
CU Health Services Center
Denver, CO
USA

Esper Boel
Novo Nordisk
Bagsvaerd
Denmark

Yu Cao
Central China Normal University
Wuhan City
P.R. China

Martin F. Desimone
Analytical and Physical Chemistry Department
Argentina

Vittorio Fineschi
Department of Anatomical, Histological, Forensic and Orthopaedic Sciences
Rome
Italy

Peter Goodwin
Los Alamos National Laboratory
Los Alamos, NM
USA

Aya Jakobovits
UroGenesys
Santa Monica, CA
USA

Alexander M. Klibanov
Massachusetts Institute of Technology
Cambridge, MA
USA

Haripada Maity
Eli Lilly and Company
Branchburg, NJ
USA

Ambikanandan Misra
Faculty of Pharmacy
Vadodara
India

Siddavaram Nagini
Department of Biochemistry & Biotechnology
Tamil Nadu
India

Fritz Poulsen
Novo Nordisk
Bagsvaerd
Denmark

Theodore Randolph
University of Colorado
Boulder, CO
USA

Cynthia Stevenson
Nektar Therapeutics
San Diego, CA
USA

Sergey Tetin
Abbott Diagnostics Division
Abbott Park, IL
USA

Susumu Uchiyama
Osaka University
Osaka
Japan

Kursheed Anwer
Expression Genetics
Huntsville, AL
USA

Jeff W. M. Bulte
The Johns Hopkins University School of Medicine
Baltimore, MD
USA

John Carpenter
CU Health Services Center
Denver, CO
USA

Michael L. Doyle (Biography
Michael L. Doyle

Dr. Doyle is Senior Principal Investigator of Protein Science at Bristol-Myers Squibb Pharmaceuticals, Inc. He has 25 years of drug discovery experience in biophysical characterization of protein drugs and targets. Michael earned his PhD in Protein Biophysical Chemistry at the University of Colorado, Boulder. He was a founding member of the Molecular Interactions Group of Association of Biomolecular Resource Facilities (ABRF), where he played a leading role in developing protein interaction systems to benchmark molecular interaction technologies across multiple laboratories. Michael has published 80 scientific articles and Co-Edited “Biocalorimetry 2: Applications of Calorimetry in the Biological Sciences.

)

Protein Science Department
Bristol-Myers Squibb Research and Development
Princeton, NJ
USA

Daniel Gomez
University of Buenos Aires
Buenos Aires
Argentina

Solomon Habtemariam
Herbal Analysis Services & Pharmacognosy Research Laboratories
Kent
UK

Lutz Jermutus
Cardiovascular & Metabolic Diseases iMED
Zurich
Switzerland

Zongjin Li
Department of Pathophysiology
Nankai University School of Medicine
Tianjin
China

Mark Manning
Legacy BioDesign
Loveland, CO
USA

Marcia Moss
BioZyme Inc.
Apex, NC
USA

Shuming Nie
Emory Univ. and the Georgia Institute of Technology
Atlanta, GA
USA

Colin Pouton
Monash University
Victoria
Australia

Mark Saifer
Mountain View Pharm
CA
USA

Mary Stickelmeyer
Lilly Research Laboratories
Indianapolis, IN
USA

Gian M. Tiboni (Biography
Gian M. Tiboni

Gian Mario Tiboni, MD, is associate professor of Obstetrics and Gynecology at the School of Medicine at the University of Chieti Pescara, Italy. He has published more than 70 scientific publications in peer-reviewed journals. He is currently director of the Assisted Reproduction Technologies Unit at the University of Chieti Pescara. Dr. Tiboni has research interest in infertility, assisted reproductive technology and reproductive toxicology.

)

Department of Medicine and Aging Science
Liberata
Italy

Giovanni Li Volti
Department of Biomedical and Biotechnological Sciences
Catania
Italy


Advertisement
Global Biotechnology Congress 2017Drug Discovery and Therapy World Congress 201711th Pharmaceutical Logistics event

Related Journals




Related eBooks



Webmaster Contact: urooj@benthamscience.org Copyright © 2017 Bentham Science